| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 73547-70-3 | 頭孢他啶二鹽酸鹽; (6R,7R)-7-[[(2Z)-2-(2-氨基-1,3-噻唑-4-基)-2-(1-羧基-1-甲基乙氧基)亞氨乙酰]氨基]-8-? | Ceftazidime dihydrochloride; 1-[[(6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyClo[4.2.0]oct-2-en-3-yl]methyl]pyridinium chloride monohydrochloride |  | C22H23N6O7S2.Cl.HCl | 詳情 | 供應(yīng)商 |
| 114798-26-4 | 洛沙坦; 2-丁基-4-氯-5-(羥甲基)-1-[[2'-(1H-四氮唑-5-)聯(lián)苯基-4-]甲基]咪唑 | Losartan; 2-Butyl-4-chloro-1-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]imidazole-5- methanol |  | C22H23ClN6O | 詳情 | 供應(yīng)商 |
| 93859-26-8 | Acetamide,N-[5-[bis[2-(acetyloxy)ethyl]amino]-2-[2-(2-chloro-4,6-dinitrophenyl)diazenyl]phenyl]-; Acetamide,N-[5-[bis[2-(acetyloxy)ethyl]amino]-2-[(2-chloro-4,6-dinitrophenyl)azo]phenyl]-(9CI) |  | C22H23ClN6O9 | 詳情 | 供應(yīng)商 | |
| 124556-76-9 | 1,2,4-Triazolo[3,4-a]phthalazin-3(2H)-one,8-chloro-2-[3-(4-phenyl-1-piperazinyl)propyl]- |  | C22H23ClN6O | 詳情 | 供應(yīng)商 | |
| 124750-92-1 | losartan |  | C22H23ClN6O | 詳情 | 供應(yīng)商 | |
| 114798-36-6 | 氯沙坦甲醛 | Losartan Carboxaldehyde Discontinued see product # L470505; 2-Butyl-4-chloro-1-[[2(1H-tetrazol-5-yl)[1,1biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxaldehyde; DUP 167; EXP 3179; Losartan Carboxaldehyde Discontinued see product # L470505; Losartan Carboxaldehyde; 2-(Butyl-d3)-4-chloro-1-[[2(1H-tetrazol-5-yl)[1,1biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxaldehyde; Losartan Carboxaldehyde-d3 |  | C22H23ClN6O | 詳情 | 供應(yīng)商 |
| 165276-38-0 | Losartan Impurity G; Losartan Impurity G; Losartan Imidazo[1,5-b]isoquinoline Impurity |  | C22H23ClN6O | 詳情 | 供應(yīng)商 | |
| 1006062-28-7 | Losartan Impurity D; Losartan Impurity D; Losartan Trityl Ether |  | C22H23ClN6O | 詳情 | 供應(yīng)商 |